Our Technology


CeraMAPs™


The Future of Vaccine Delivery



CeraMAPs™ are unique in the vaccination world. Exploiting the unique nano-porous properties of biocompatible, inert ceramics, CeraMAPs™ excel in the targeted delivery of a high-vaccine loads in the skin. Unlike traditional intramuscular vaccines, they offer a painless, user-friendly experience, making vaccination easier, more cost-effective and more accessible.



Our advanced nano porous ceramic material allows us to store active compounds, like vaccines, directly within our microneedles. This feature offers a significant edge, enhancing loading capacity and enabling tailored release profiles for swift action and long-lasting effectiveness.

Nano Porous Technology

Enhanced Efficiency


Our microneedles offer increased efficiency by delivering vaccines directly into the skin, significantly reducing the required antigen dosage. This aims to achieve the same immunological response as traditional intramuscular injections but with 5 to 20X less antigen and no adjuvants.


Our microneedles excel in painless and precise vaccine delivery. With each needle measuring less than 0.5mm, they offer pinpoint accuracy, targeting just above nerves and vessels to ensure a  painless and blood-free experience.

Painless & Precise

Beyond Cold Chain


We've made significant strides in achieving thermostability with our advanced dry formulation and manufacturing process, reducing the dependence on cold chain requirements and simplifying vaccine distribution.

Our Latest Research

Virus Research, September 2023
Virus Research, September 2023
Establishing immunogenicity and safety of needle-free intradermal delivery by nanoporous ceramic skin patch of mRNA SARS-CoV-2 vaccine as a revaccination strategy in healthy volunteers. Click on image to learn more.
European Journal of Pharmaceutics and Biopharmaceutics, March 2019
European Journal of Pharmaceutics and Biopharmaceutics, March 2019
Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses. Click on image to learn more.
Frontiers, December 2017
Frontiers, December 2017
Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid. Click on image to learn more.
International Journal of Pharmaceutics, August 2015
International Journal of Pharmaceutics, August 2015
Controlled release of a model vaccine by nanoporous ceramic microneedle arrays. Click on image to learn more.
unsplash